Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neurofibromatosis 1 × Radiation × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 79 Prostatic Neoplasms 57 Carcinoma, Non-Small-Cell Lung 53 Breast Neoplasms 53 Esophageal Neoplasms 48 Rectal Neoplasms 41 Lung Neoplasms 41 Squamous Cell Carcinoma of Head and Neck 33 Head and Neck Neoplasms 33 Brain Neoplasms 33 Gliosarcoma 30 Pancreatic Neoplasms 29 Uterine Cervical Neoplasms 28 Neoplasms 25 Glioma 24 Neoplasm Metastasis 23 Sarcoma 22 Oropharyngeal Neoplasms 21 Melanoma 19 Esophageal Squamous Cell Carcinoma 19 Astrocytoma 18 Adenocarcinoma Of Esophagus 15 Stomach Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Carcinoma, Squamous Cell 12 Urinary Bladder Neoplasms 11 Mouth Neoplasms 11 Lymphoma, Follicular 11 Central Nervous System Neoplasms 11 Carcinoma 11

Interventions

AZD 6244 19 trametinib 5 Lovastatin 5 Deoxycholic Acid 4 mirdametinib 3 Lasers, Solid-State 3 pirfenidone 2 fludarabine 2 binimetinib 2 Vincristine 2 Vinblastine 2 Transcranial Direct Current Stimulation 2 Specimen Handling 2 Sirolimus 2 Polidocanol 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Lasers 2 Lamotrigine 2 Inhalation 2 Everolimus 2 Carboplatin 2 Blood Specimen Collection 2 Biopsy 2 Acetylcysteine 2 tipifarnib 1 thymoglobulin 1 talimogene laherparepvec 1 pomalidomide 1 peginterferon alfa-2b 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07521657 2026-04-13

NF118

University of Alabama at Birmingham

Phase 2 Not yet recruiting

Glioblastoma, Glioma, Neurofibromatosis 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡